In vivo treatment with W3/13 (anti-pan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats.
The involvement of phenotypically defined cells in the pathogenesis of adjuvant arthritis in rats has been investigated in two different ways. Firstly, immunohistochemical methods have been used to characterize the cellular composition of the arthritic synovial tissue, in particular the pannus tissue close to the destroyed cartilage. It is shown that T-helper lymphocytes dominate the lymphoid infiltrates, and that large numbers of cells expressing Ia are present in the pannus. Secondly, different anti-T cell monoclonal antibodies have been injected into rats in vivo and disease course and phenotypes of synovial cells investigated after different types of treatment. It is shown that the injection of W3/13 (anti-pan T-cell antibodies) delays the development of adjuvant arthritis, whereas a complete elimination of the suppressor/cytotoxic T-cell subset after injection of OX8 antibodies does not affect the disease course.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D001168:Arthritis / Q000276:immunology*; D001169:Arthritis, Experimental / Q000276:immunology* / Q000473:pathology; D002358:Cartilage, Articular / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D010641:Phenotype; D051381:Rats; D011917:Rats, Inbred Lew; D013154:Spleen / Q000276:immunology / Q000473:pathology; D013583:Synovial Membrane / Q000276:immunology / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
D000911:Antibodies, Monoclonal; D000949:Histocompatibility Antigens Class II